Price Performance
- Day's Low
- ₹470.85
- Day's High
- ₹483
₹ 482
- 52-w low
- ₹399.95
- 52-w high
- ₹686.3
482
- Day's open
₹483 - Previous close
₹474.149994 - VWAP
₹479.77 - Lower price band
₹379.35 - Upper price band
₹568.95
Today's Market Action
The last traded share price of Balaxi Pharmaceuticals Ltd was 482.00 up by 1.66% on the NSE. The total volume of shares on NSE and BSE combined was 987 shares. Its total combined turnover was Rs 0.05 crores.
Medium and Long Term Market Action
Balaxi Pharmaceuticals Ltd hit a 52-week high of 686.3 on 12-02-2024 and a 52-week low of 399.95 on 31-10-2023.
The stock price of Balaxi Pharmaceuticals Ltd is down by -24% over the last one month. It is down by -13.23% over the last one year. Don't forget to check the full stock price history in the table below.
Fundamentals
-
Market Cap (Cr): 490
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About
Data not available.
FAQ's
What is Share Price of Balaxi Pharmaceuticals Ltd?
What is the Market Cap of Balaxi Pharmaceuticals Ltd?
What is PE Ratio of Balaxi Pharmaceuticals Ltd?
What is PB Ratio of Balaxi Pharmaceuticals Ltd?
What is the CAGR of Balaxi Pharmaceuticals Ltd?
How to Buy Balaxi Pharmaceuticals Ltd Share?
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
Pros
Above Average Sustainable RoE
Asset Light Business
Cons
Momentum Strength
Poor Cash Flow Conversion
Highly Cyclical Industry
Poor Capital Allocation
Poor Working Capital Cycle
Below Average Growth Rate
Low Shareholder Pedigree
Valuation Analysis
Margin of safety
(19/03/2024)
(19/03/2024)
101
100.00%
100.00% People are bullish about Balaxi Pharmaceuticals Ltd
0.00%
0.00 % People are bearish about Balaxi Pharmaceuticals Ltd